J0139 HCPCS Level II code: Injection, adalimumab, 1 mg
J0139 is the HCPCS code for “Injection, adalimumab, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0139Injection, adalimumab, 1 mg
Short description: Inj, adalimumab, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0139 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2025
Where J0139 sits
- 1J codesDrugs administered other than orally
- 2Active code J0139Injection, adalimumab, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0139 mean?
J0139 is the HCPCS code for “Injection, adalimumab, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0139?
CMS lists J0139’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0139
All J codesJ0133Injection, acyclovir, 5 mgJ0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mgJ0135Injection, adalimumab, 20 mgJ0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mgJ0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mgJ0138Injection, acetaminophen 10 mg and ibuprofen 3 mgJ0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mgJ0163Injection, epinephrine in sodium chloride (endo), 0.1 mgJ0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg